CJC-1295 without DAC is a synthetic growth hormone–releasing hormone analog designed for research focused on pulsatile growth hormone signaling and endocrine pathway modulation. Unlike DAC-modified variants, this non-DAC form is studied for its shorter activity window, making it valuable in models that examine natural rhythm-based hormone release patterns. Its structure has generated strong scientific interest due to its potential role in supporting investigations around pituitary signaling, growth hormone pulse dynamics, and downstream IGF-1 pathway activity. Researchers often evaluate CJC-1295 without DAC in comparison to longer-acting analogs to better understand duration-dependent signaling behavior. As peptide research continues to explore precision-based endocrine modulation, CJC-1295 without DAC remains an important compound in investigational hormone regulation studies.